Carl Valenstein
Advertisement
Carl Valenstein is a partner with Morgan Lewis and co-leads the firm’s Environmental, Social, and Governance (ESG) & Sustainability team. Shabeena Sharak, a summer associate with the firm, contributed to the development of the column.
Articles by Carl Valenstein
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
2
Eli Lilly to Acquire AtaiBeckley for $2.8 Billion
3
Pharmaceutical Executive Daily: FDA Approves Lipfendra
4
The Power of Better Questions: How Great Leaders Balance Risk, Growth and Curiosity
5